Intra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes

Diabetes Care

Volumn 30, Issue 7, 2007, Pages 1898-1900

  Sibley, Shalamar D ^a   De Boer, Ian H ^b   Steffes, Michael W ^a   Brunzell, John D ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ARTICLE; BODY MASS; CONTROLLED STUDY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; SMOKING HABIT; URINARY EXCRETION;

ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447129477     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2345     Document Type: Article

References (26)

1. Lokkegaard N, Haupter I, Kristensen TB: Microalbuminuria in obesity. Scand J Urol Nephrol 26:275-278, 1992
2. Metcalf PA, Scragg RK, Dryson E: Associations between body morphology and microalbuminuria in healthy middle-aged European, Maori, and Pacific Island New Zealanders. Int J Obes Relat Metab Disord 21:203-210, 1997
3. Reid M, Bennett F, Wilks R, Forrester T: Microalbuminuria, renal function, and waist:hip ratio in black hypertensive Jamaicans. J Hum Hypertens 12:221-227, 1998
4. Solerte SB, Fioravanti M, Pezza N, Locatelli M, Schifino N, Cerutti N, Severgnini S, Rondanelli M, Ferrari E: Hyperviscosity and microalbuminuria in central obesity: relevance to cardiovascular risk. Int J Obes Relat Metab Disord 21:417-423, 1997
5. Valensi P, Assayag M, Busby M, Paries L, Lormeau B, Attali JR: Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord 20:574-579, 1996
6. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG: Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study. Arch Intern Med 158:1933-1939, 1998
7. Dingel DR, Goldberg A-P, Mayuga RS, Kairis GM, Weir MR: Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 28:127-132, 1996
8. Ribstein J, du Cailar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 26:610-615, 1995
9. Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G, Dichiara MA, Merlino G, Cecala MG: Central obesity and hypertension: relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens 7:314-320, 1994
10. Scaglione R, Ganguzza A, Corrao S, Parrinello G, Merlino G, Dichiara MA, Arnone S, D'Aubert MD: Central obesity and hypertension: pathophysiologic role of renal hemodynamics and function. Int J Obes Relat Metab Disord 19:403-409, 1995
11. Solerte SB, Rondanelli M, Giacchero R, Stabile M, Lovati E, Cravello L, Pontiggia B, Vignati G, Ferrari E, Fioravanti M: Serum glucagon concentration and hyperinsulinemia influence renal hemodynamics and urinary protein loss in normotensive patients with central obesity. Int J Obes Relat Metab Disord 23:997-1003, 1999
12. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21-28, 2006
13. Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N: Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetes patients: the EURODIAB Prospective Complications Study. Diabetologia 47:1020-1028, 2004
14. Stuhldreher WL, Becker DJ, Drash AL, Ellis D, Kuller LH, Wolfson SK, Orchard TJ: The association of waist/hip ratio with diabetes complications in an adult IDDM population. J Clin Epidemiol 47:447-456, 1994
15. DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35:530-545, 1986
16. Department of Health and Human Services: The prevalence study. In The Lipid Research Clinics Population Studies Data Book. Vol. 1. Washington, DC, U.S. Govt. Printing Office, 1980, p. 1-115 (NIH publ. no. 80-1527)
17. Metropolitan Life Insurance Company: Metropolitan height and weight tables. Stat Bull Metropolitan Life Insurance Co 64:2-9, 1983
18. DCCT Research Group: Epidemiology of Diabetes Interventions and Complications: design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22:99-111, 1999
19. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD: Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT: Diabetes Control and Complications Trial. JAMA 280:140-146, 1998 [erratum in JAMA 280:1484, 1998]
20. Sibley SD, Thomas W, de Boer I, Brunzell JD, Steffes MW: Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity. Am J Kidney Dis 47:223-232, 2006
21. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, Steffes MW, Weiss NS, Brunzell JD, the DCCT/EDIC Research Group: Central obesity, incident microalbuminuria, and change in creatinine clearance in the Epidemiology of Diabetes Interventions and Complications Study. J Am Soc Nephrol 18:235-243, 2007
22. Fujimoto WY, Abbate SL, Kahn SE, Hokanson JE, Brunzell JD: The visceral adiposity syndrome in Japanese-American men. Obesity Research 2:364-371, 1994
23. Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, Fujimoto WY: Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 21:483-487, 1986
24. Potretzke AM, Schmitz KH, Jensen MD: Preventing overestimation of pixels in computed tomography assessment of visceral fat. Obes Res 12:1698-1701, 2004
25. Molitch ME, Steffes M, Cleary PA, Nathan DM: Baseline analysis of renal function in the Diabetes Control and Complications Trial. Kidney Int 43:668-674, 1993
26. DCCT Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47:1703-1720, 1995